Net Cash Provided by (Used in) Financing Activities in USD of T2 Biosystems, Inc. from 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
T2 Biosystems, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2015 to Q1 2024.
  • T2 Biosystems, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $2.2M, a 81.4% decline year-over-year.
  • T2 Biosystems, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $52.7M, a 81.3% increase from 2022.
  • T2 Biosystems, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $29.1M, a 41.5% increase from 2021.
  • T2 Biosystems, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $20.5M, a 76% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

T2 Biosystems, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.2M -$9.65M -81.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q1 2023 $11.8M +$10.6M +886% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q1 2022 $1.2M +$1.15M +2168% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q1 2021 $53K -$40M -99.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $40.1M +$40.4M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q1 2019 -$344K +$4K +1.15% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 -$348K -$34K -10.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 -$314K -$165K -111% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q1 2016 -$149K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08

T2 Biosystems, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $52.7M +$23.6M +81.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $29.1M +$8.52M +41.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $20.5M -$65.1M -76% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $85.6M +$79.3M +1248% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
2019 $6.35M -$43.3M -87.2% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 $49.7M +$31.2M +168% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $18.5M -$33.3M -64.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-16
2016 $51.8M +$6.58M +14.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
2015 $45.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.